Genprex Inc (GNPX) FinancialsGNPXGenprex Inc

Evaluating the bottom line, Genprex Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -203.86%, provide a clear picture of how effectively GNPX converts its operational activities into shareholder value.

In the context of the broader market, GNPX competes directly with industry leaders such as XRTX and KAPA. With a market capitalization of $1.71M, it holds a significant position in the sector. When comparing efficiency, GNPX's gross margin of N/A stands against XRTX's N/A and KAPA's N/A. Such benchmarking helps identify whether Genprex Inc is trading at a premium or discount relative to its financial performance.

Genprex Inc has reported no revenue for several quarters, with total revenue of $0.00 in Q4 2024 and Q2 2025. The company has consistently posted negative net income, with losses exceeding $4 million in multiple quarters, indicating significant financial instability.